Gilgamesh Pharmaceuticals Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Gilgamesh Pharmaceuticals's estimated annual revenue is currently $5M per year.(i)
Gilgamesh Pharmaceuticals's estimated revenue per employee is $155,000

Name	Title	Email/Phone
1 Jonathan Sporn	Founder, CEO	Reveal Email/Phone
2 Andrew Kruegel	Co-Founder and Head Chemistry	Reveal Email/Phone
3 Gerard Marek	CMO	Reveal Email/Phone
4 Andrew Kruegel	Chief Scientific Officer	Reveal Email/Phone
5 Jorge Quiroz	Chief Strategy & Development Officer	Reveal Email/Phone
6 Eric Austin	Head Toxicology and ADME	Reveal Email/Phone
7 Jason Winters	Head Clinical Operations	Reveal Email/Phone
8 William Leong	EVP, Head CMC	Reveal Email/Phone
9 Yoni Falkson	Chief Operating Officer	Reveal Email/Phone
10 Ed Christian	Executive Director Clinical Sciences	Reveal Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Dermavant Scien...	$81.4M	375	40%	N/A	N/A
#2 Metrum Research...	$16.9M	109	22%	N/A	N/A
#3 Clovis Oncology	$156.1M	120	-70%	$145M	N/A
#4 ArcherDX	$2.9M	37	-24%	$150M	N/A
#5 Inscripta	$1.3M	17	0%	$459.5M	N/A
#6 Cerapedics	$49.2M	254	15%	$180.7M	N/A
#7 Stone Clinical ...	$7M	45	-2%	N/A	N/A
#8 Apellis Pharmac...	$256.3M	840	9%	$168.5M	N/A
#9 CreoSalus	$4.2M	15	-32%	N/A	N/A
#10 MSBiotec	$10.1M	48	-9%	N/A	N/A

keywords:N/A

N/A

Total Funding

Number of Employees

$5M

Revenue (est)

Employee Growth %

N/A

Valuation

N/A

Accelerator

NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Gilgamesh Pharmaceuticals, a mental health?focused biotechnology company developing novel...

Novel treatments for depression and other neuropsychiatric disorders. NEW YORK, March 24, 2022 /PRNewswire/ -- Gilgamesh Pharmaceuticals,...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Rosemunde Copen...	$3.5M	32	3%	N/A
#2 R R Oomerbhoy P...	$4.8M	32	-3%	N/A
#3 Ruffian Games	$5.2M	32	-18%	N/A
#4 Western Mortgag...	$7.4M	32	-14%	N/A
#5 Horst Realty	$4.1M	32	3%	N/A